1. |
- Mohammad, Aladdin, et al.
(author)
-
Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).
- 2016
-
In: Annals of the Rheumatic Diseases. - : BMJ. - 1468-2060 .- 0003-4967. ; 75:2, s. 396-401
-
Journal article (peer-reviewed)abstract
- Conventional treatment of eosinophilic granulomatosis with polyangiitis (EGPA) (Churg-Strauss) with glucocorticoids, with or without additional immunosuppressive drugs, is limited by partial efficacy, frequent toxicity and a high relapse rate. Rituximab is a licensed treatment for granulomatosis with polyangiitis and microscopic polyangiitis and is of potential benefit to patients with EGPA.
|
|